HEADER TRANSFERASE 08-JUN-06 2IUY TITLE CRYSTAL STRUCTURE OF AVIGT4, A GLYCOSYLTRANSFERASE INVOLVED TITLE 2 IN AVILAMYCIN A BIOSYNTHESIS COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AVIGT4; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES VIRIDOCHROMOGENES; SOURCE 3 ORGANISM_TAXID: 1938; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 OTHER_DETAILS: DSM 40721 KEYWDS GLYCOSYLTRANSFERASE, TRANSFERASE, ANTIBIOTICS, FAMILY GT-4, KEYWDS 2 AVILAMYCIN A EXPDTA X-RAY DIFFRACTION AUTHOR C.MARTINEZ-FLEITES,M.PROCTOR,S.ROBERTS,D.N.BOLAM, AUTHOR 2 H.J.GILBERT,G.J.DAVIES REVDAT 3 24-FEB-09 2IUY 1 VERSN REVDAT 2 20-DEC-06 2IUY 1 JRNL REVDAT 1 11-OCT-06 2IUY 0 JRNL AUTH C.MARTINEZ-FLEITES,M.PROCTOR,S.ROBERTS,D.N.BOLAM, JRNL AUTH 2 H.J.GILBERT,G.J.DAVIES JRNL TITL INSIGHTS INTO THE SYNTHESIS OF LIPOPOLYSACCHARIDE JRNL TITL 2 AND ANTIBIOTICS THROUGH THE STRUCTURES OF TWO JRNL TITL 3 RETAINING GLYCOSYLTRANSFERASES FROM FAMILY GT4 JRNL REF CHEM.BIOL. V. 13 1143 2006 JRNL REFN ISSN 1074-5521 JRNL PMID 17113996 JRNL DOI 10.1016/J.CHEMBIOL.2006.09.005 REMARK 2 REMARK 2 RESOLUTION. 2.1 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 35293 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1902 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2504 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1760 REMARK 3 BIN FREE R VALUE SET COUNT : 130 REMARK 3 BIN FREE R VALUE : 0.3170 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4994 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 440 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : -0.02000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.234 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.197 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.127 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.621 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5214 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7136 ; 1.686 ; 1.963 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 676 ; 7.753 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 209 ;32.680 ;22.249 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 716 ;14.726 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 47 ;19.869 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 784 ; 0.112 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4067 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2467 ; 0.197 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3454 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 396 ; 0.142 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 53 ; 0.222 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.363 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3457 ; 1.071 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5394 ; 1.566 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2027 ; 2.757 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1742 ; 4.218 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2IUY COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-JUN-06. REMARK 100 THE PDBE ID CODE IS EBI-29037. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97770 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42291 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 73.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.2 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG3350, 0.2M LI2SO4, 0.1M REMARK 280 MES PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.91450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 11 REMARK 465 ARG A 12 REMARK 465 MSE B 11 REMARK 465 ARG B 12 REMARK 465 GLY B 71 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 352 CD CE NZ REMARK 470 ARG B 72 NE CZ NH1 NH2 REMARK 470 LYS B 352 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 322 C ARG A 323 N -0.164 REMARK 500 GLU B 320 CG GLU B 320 CD 0.093 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 91 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 234 NE - CZ - NH1 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG A 234 NE - CZ - NH2 ANGL. DEV. = -5.4 DEGREES REMARK 500 ARG A 323 CD - NE - CZ ANGL. DEV. = 9.1 DEGREES REMARK 500 ARG A 323 NE - CZ - NH1 ANGL. DEV. = 7.9 DEGREES REMARK 500 ARG A 323 NE - CZ - NH2 ANGL. DEV. = -7.1 DEGREES REMARK 500 ARG A 322 O - C - N ANGL. DEV. = -14.1 DEGREES REMARK 500 ARG A 323 C - N - CA ANGL. DEV. = 25.0 DEGREES REMARK 500 ARG B 235 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 TRP B 256 CA - CB - CG ANGL. DEV. = -13.5 DEGREES REMARK 500 GLY B 258 N - CA - C ANGL. DEV. = -15.2 DEGREES REMARK 500 ARG B 323 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG B 323 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 65 56.32 -154.12 REMARK 500 ARG A 72 130.05 -36.33 REMARK 500 ASN A 129 77.17 -119.35 REMARK 500 ALA A 265 70.58 52.27 REMARK 500 ALA B 65 59.42 -150.43 REMARK 500 ALA B 265 76.51 52.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TRP B 256 GLY B 257 147.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 VAL B 339 22.3 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1353 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1354 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A1353 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B1355 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IV3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AVIGT4, A REMARK 900 GLYCOSYLTRANSFERASE INVOLVED IN AVILAMYCIN A REMARK 900 BIOSYNTHESIS DBREF 2IUY A 11 352 UNP Q93KV2 Q93KV2_STRVR 1 342 DBREF 2IUY B 11 352 UNP Q93KV2 Q93KV2_STRVR 1 342 SEQRES 1 A 342 MSE ARG PRO LEU LYS VAL ALA LEU VAL ASN ILE PRO LEU SEQRES 2 A 342 ARG VAL PRO GLY SER ASP ALA TRP ILE SER VAL PRO PRO SEQRES 3 A 342 GLN GLY TYR GLY GLY ILE GLN TRP VAL VAL ALA ASN LEU SEQRES 4 A 342 MSE ASP GLY LEU LEU GLU LEU GLY HIS GLU VAL PHE LEU SEQRES 5 A 342 LEU GLY ALA PRO GLY SER PRO ALA GLY ARG PRO GLY LEU SEQRES 6 A 342 THR VAL VAL PRO ALA GLY GLU PRO GLU GLU ILE GLU ARG SEQRES 7 A 342 TRP LEU ARG THR ALA ASP VAL ASP VAL VAL HIS ASP HIS SEQRES 8 A 342 SER GLY GLY VAL ILE GLY PRO ALA GLY LEU PRO PRO GLY SEQRES 9 A 342 THR ALA PHE ILE SER SER HIS HIS PHE THR THR ARG PRO SEQRES 10 A 342 VAL ASN PRO VAL GLY CYS THR TYR SER SER ARG ALA GLN SEQRES 11 A 342 ARG ALA HIS CYS GLY GLY GLY ASP ASP ALA PRO VAL ILE SEQRES 12 A 342 PRO ILE PRO VAL ASP PRO ALA ARG TYR ARG SER ALA ALA SEQRES 13 A 342 ASP GLN VAL ALA LYS GLU ASP PHE LEU LEU PHE MSE GLY SEQRES 14 A 342 ARG VAL SER PRO HIS LYS GLY ALA LEU GLU ALA ALA ALA SEQRES 15 A 342 PHE ALA HIS ALA CYS GLY ARG ARG LEU VAL LEU ALA GLY SEQRES 16 A 342 PRO ALA TRP GLU PRO GLU TYR PHE ASP GLU ILE THR ARG SEQRES 17 A 342 ARG TYR GLY SER THR VAL GLU PRO ILE GLY GLU VAL GLY SEQRES 18 A 342 GLY GLU ARG ARG LEU ASP LEU LEU ALA SER ALA HIS ALA SEQRES 19 A 342 VAL LEU ALA MSE SER GLN ALA VAL THR GLY PRO TRP GLY SEQRES 20 A 342 GLY ILE TRP CYS GLU PRO GLY ALA THR VAL VAL SER GLU SEQRES 21 A 342 ALA ALA VAL SER GLY THR PRO VAL VAL GLY THR GLY ASN SEQRES 22 A 342 GLY CYS LEU ALA GLU ILE VAL PRO SER VAL GLY GLU VAL SEQRES 23 A 342 VAL GLY TYR GLY THR ASP PHE ALA PRO ASP GLU ALA ARG SEQRES 24 A 342 ARG THR LEU ALA GLY LEU PRO ALA SER ASP GLU VAL ARG SEQRES 25 A 342 ARG ALA ALA VAL ARG LEU TRP GLY HIS VAL THR ILE ALA SEQRES 26 A 342 GLU ARG TYR VAL GLU GLN TYR ARG ARG LEU LEU ALA GLY SEQRES 27 A 342 ALA THR TRP LYS SEQRES 1 B 342 MSE ARG PRO LEU LYS VAL ALA LEU VAL ASN ILE PRO LEU SEQRES 2 B 342 ARG VAL PRO GLY SER ASP ALA TRP ILE SER VAL PRO PRO SEQRES 3 B 342 GLN GLY TYR GLY GLY ILE GLN TRP VAL VAL ALA ASN LEU SEQRES 4 B 342 MSE ASP GLY LEU LEU GLU LEU GLY HIS GLU VAL PHE LEU SEQRES 5 B 342 LEU GLY ALA PRO GLY SER PRO ALA GLY ARG PRO GLY LEU SEQRES 6 B 342 THR VAL VAL PRO ALA GLY GLU PRO GLU GLU ILE GLU ARG SEQRES 7 B 342 TRP LEU ARG THR ALA ASP VAL ASP VAL VAL HIS ASP HIS SEQRES 8 B 342 SER GLY GLY VAL ILE GLY PRO ALA GLY LEU PRO PRO GLY SEQRES 9 B 342 THR ALA PHE ILE SER SER HIS HIS PHE THR THR ARG PRO SEQRES 10 B 342 VAL ASN PRO VAL GLY CYS THR TYR SER SER ARG ALA GLN SEQRES 11 B 342 ARG ALA HIS CYS GLY GLY GLY ASP ASP ALA PRO VAL ILE SEQRES 12 B 342 PRO ILE PRO VAL ASP PRO ALA ARG TYR ARG SER ALA ALA SEQRES 13 B 342 ASP GLN VAL ALA LYS GLU ASP PHE LEU LEU PHE MSE GLY SEQRES 14 B 342 ARG VAL SER PRO HIS LYS GLY ALA LEU GLU ALA ALA ALA SEQRES 15 B 342 PHE ALA HIS ALA CYS GLY ARG ARG LEU VAL LEU ALA GLY SEQRES 16 B 342 PRO ALA TRP GLU PRO GLU TYR PHE ASP GLU ILE THR ARG SEQRES 17 B 342 ARG TYR GLY SER THR VAL GLU PRO ILE GLY GLU VAL GLY SEQRES 18 B 342 GLY GLU ARG ARG LEU ASP LEU LEU ALA SER ALA HIS ALA SEQRES 19 B 342 VAL LEU ALA MSE SER GLN ALA VAL THR GLY PRO TRP GLY SEQRES 20 B 342 GLY ILE TRP CYS GLU PRO GLY ALA THR VAL VAL SER GLU SEQRES 21 B 342 ALA ALA VAL SER GLY THR PRO VAL VAL GLY THR GLY ASN SEQRES 22 B 342 GLY CYS LEU ALA GLU ILE VAL PRO SER VAL GLY GLU VAL SEQRES 23 B 342 VAL GLY TYR GLY THR ASP PHE ALA PRO ASP GLU ALA ARG SEQRES 24 B 342 ARG THR LEU ALA GLY LEU PRO ALA SER ASP GLU VAL ARG SEQRES 25 B 342 ARG ALA ALA VAL ARG LEU TRP GLY HIS VAL THR ILE ALA SEQRES 26 B 342 GLU ARG TYR VAL GLU GLN TYR ARG ARG LEU LEU ALA GLY SEQRES 27 B 342 ALA THR TRP LYS MODRES 2IUY MSE A 50 MET SELENOMETHIONINE MODRES 2IUY MSE A 178 MET SELENOMETHIONINE MODRES 2IUY MSE A 248 MET SELENOMETHIONINE MODRES 2IUY MSE B 50 MET SELENOMETHIONINE MODRES 2IUY MSE B 178 MET SELENOMETHIONINE MODRES 2IUY MSE B 248 MET SELENOMETHIONINE HET MSE A 50 8 HET MSE A 178 8 HET MSE A 248 8 HET MSE B 50 8 HET MSE B 178 8 HET MSE B 248 8 HET SO4 B1353 5 HET SO4 B1354 5 HET MES A1353 12 HET MES B1355 12 HETNAM MSE SELENOMETHIONINE HETNAM SO4 SULFATE ION HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 MES 2(C6 H13 N O4 S) FORMUL 7 HOH *440(H2 O1) HELIX 1 1 GLY A 40 LEU A 56 1 17 HELIX 2 2 GLU A 82 ALA A 93 1 12 HELIX 3 3 SER A 137 CYS A 144 1 8 HELIX 4 4 ASP A 158 TYR A 162 5 5 HELIX 5 5 SER A 182 LYS A 185 5 4 HELIX 6 6 GLY A 186 CYS A 197 1 12 HELIX 7 7 GLU A 209 GLY A 221 1 13 HELIX 8 8 GLY A 231 ALA A 242 1 12 HELIX 9 9 ALA A 265 SER A 274 1 10 HELIX 10 10 CYS A 285 VAL A 290 1 6 HELIX 11 11 ALA A 304 GLY A 314 1 11 HELIX 12 12 ALA A 317 GLY A 330 1 14 HELIX 13 13 GLY A 330 ALA A 347 1 18 HELIX 14 14 GLY B 40 LEU B 56 1 17 HELIX 15 15 GLU B 82 ALA B 93 1 12 HELIX 16 16 SER B 137 CYS B 144 1 8 HELIX 17 17 ASP B 158 TYR B 162 5 5 HELIX 18 18 SER B 164 GLN B 168 5 5 HELIX 19 19 SER B 182 LYS B 185 5 4 HELIX 20 20 GLY B 186 GLY B 198 1 13 HELIX 21 21 GLU B 209 GLY B 221 1 13 HELIX 22 22 GLY B 231 ALA B 242 1 12 HELIX 23 23 ALA B 265 SER B 274 1 10 HELIX 24 24 CYS B 285 VAL B 290 1 6 HELIX 25 25 ALA B 304 GLY B 314 1 11 HELIX 26 26 ALA B 317 GLY B 330 1 14 HELIX 27 27 GLY B 330 ALA B 347 1 18 SHEET 1 AA 6 LEU A 75 VAL A 77 0 SHEET 2 AA 6 GLU A 59 LEU A 63 1 O VAL A 60 N THR A 76 SHEET 3 AA 6 LYS A 15 VAL A 19 1 O VAL A 16 N PHE A 61 SHEET 4 AA 6 VAL A 97 ASP A 100 1 O VAL A 97 N ALA A 17 SHEET 5 AA 6 ALA A 116 HIS A 121 1 O ALA A 116 N VAL A 98 SHEET 6 AA 6 CYS A 133 TYR A 135 1 O THR A 134 N HIS A 121 SHEET 1 AB 6 VAL A 224 PRO A 226 0 SHEET 2 AB 6 LEU A 201 ALA A 204 1 O LEU A 201 N GLU A 225 SHEET 3 AB 6 LEU A 175 MSE A 178 1 O LEU A 175 N VAL A 202 SHEET 4 AB 6 ALA A 244 ALA A 247 1 O ALA A 244 N LEU A 176 SHEET 5 AB 6 VAL A 278 GLY A 280 1 O VAL A 279 N ALA A 247 SHEET 6 AB 6 GLY A 294 VAL A 296 1 O GLU A 295 N GLY A 280 SHEET 1 BA 6 LEU B 75 VAL B 77 0 SHEET 2 BA 6 GLU B 59 LEU B 63 1 O VAL B 60 N THR B 76 SHEET 3 BA 6 LYS B 15 VAL B 19 1 O VAL B 16 N PHE B 61 SHEET 4 BA 6 VAL B 97 ASP B 100 1 O VAL B 97 N ALA B 17 SHEET 5 BA 6 ALA B 116 HIS B 121 1 O ALA B 116 N VAL B 98 SHEET 6 BA 6 CYS B 133 TYR B 135 1 O THR B 134 N HIS B 121 SHEET 1 BB 6 VAL B 224 PRO B 226 0 SHEET 2 BB 6 LEU B 201 ALA B 204 1 O LEU B 201 N GLU B 225 SHEET 3 BB 6 LEU B 175 MSE B 178 1 O LEU B 175 N VAL B 202 SHEET 4 BB 6 ALA B 244 ALA B 247 1 O ALA B 244 N LEU B 176 SHEET 5 BB 6 VAL B 278 GLY B 280 1 O VAL B 279 N ALA B 247 SHEET 6 BB 6 GLY B 294 VAL B 296 1 O GLU B 295 N GLY B 280 LINK C LEU A 49 N MSE A 50 1555 1555 1.32 LINK C MSE A 50 N ASP A 51 1555 1555 1.34 LINK C PHE A 177 N MSE A 178 1555 1555 1.33 LINK C MSE A 178 N GLY A 179 1555 1555 1.33 LINK C ALA A 247 N MSE A 248 1555 1555 1.33 LINK C MSE A 248 N SER A 249 1555 1555 1.33 LINK C LEU B 49 N MSE B 50 1555 1555 1.32 LINK C MSE B 50 N ASP B 51 1555 1555 1.32 LINK C PHE B 177 N MSE B 178 1555 1555 1.33 LINK C MSE B 178 N GLY B 179 1555 1555 1.33 LINK C ALA B 247 N MSE B 248 1555 1555 1.33 LINK C MSE B 248 N SER B 249 1555 1555 1.34 CISPEP 1 VAL A 34 PRO A 35 0 -2.92 CISPEP 2 VAL B 34 PRO B 35 0 -2.92 CISPEP 3 GLY B 258 ILE B 259 0 1.63 SITE 1 AC1 6 TYR B 39 GLY B 179 ARG B 180 LYS B 185 SITE 2 AC1 6 HOH B2231 HOH B2232 SITE 1 AC2 3 ARG A 126 ARG B 126 PRO B 130 SITE 1 AC3 10 GLN A 37 GLU A 229 VAL A 230 GLY A 231 SITE 2 AC3 10 ARG A 234 GLY A 348 ALA A 349 HOH A2138 SITE 3 AC3 10 HOH A2204 HOH A2205 SITE 1 AC4 10 GLN B 37 GLY B 38 VAL B 230 GLY B 231 SITE 2 AC4 10 ARG B 234 GLY B 348 HOH B2149 HOH B2233 SITE 3 AC4 10 HOH B2234 HOH B2235 CRYST1 47.521 73.829 92.173 90.00 90.65 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021043 0.000000 0.000239 0.00000 SCALE2 0.000000 0.013545 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010850 0.00000